United States · FDA National Drug Code directory

Deferasirox Oral Granules

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 42806-371_2b205859-07ad-1703-e063-6394a90ac140
Product NDC: 42806-371
Form: GRANULE
Composition / generic term: deferasirox
Labeler: EPIC PHARMA, LLC
Marketing category: ANDA
Marketing start / end (source format): 20221006
Source listing expiry: 20261231

Source-listed ingredients

DEFERASIROX — 90 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 PACKET in 1 CARTON (42806-371-30) / 1 GRANULE in 1 PACKET · 42806-371-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →